Ind-Swift Faces Financial Struggles Amid Significant Stock Volatility and Declining Performance
Ind-Swift, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low and has seen a notable decline over the past three days. The company faces financial challenges, including a negative book value and a high debt-to-equity ratio, alongside a significant drop in quarterly profits.
Ind-Swift, a microcap player in the Pharmaceuticals & Drugs industry, has experienced significant volatility, hitting a new 52-week low of Rs. 13.02 today. The stock has underperformed its sector by 1.14% and has seen a consecutive decline over the past three days, resulting in a total drop of 7.33%. In terms of moving averages, Ind-Swift is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. Over the past year, the stock has recorded a performance decline of 20.18%, contrasting sharply with the Sensex, which has only dipped by 0.31% during the same period.
The company's financial health raises concerns, as it has a negative book value and a high debt-to-equity ratio, suggesting weak long-term fundamental strength. Recent quarterly results also reflect challenges, with a reported PAT of Rs. -5.50 crore, marking a significant decline of 140.1%. Overall, Ind-Swift's performance metrics indicate a troubling trajectory, with multiple technical indicators signaling bearish conditions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
